Holders over time
- TMO
- GILD
| Quarter | TMO | GILD |
|---|---|---|
| Q4 2020 | 33 holders, $39.2bn | 27 holders, $13.4bn |
| Q1 2021 | 35 holders, $36.5bn | 24 holders, $14.5bn |
| Q2 2021 | 33 holders, $38.3bn | 18 holders, $14.9bn |
| Q3 2021 | 32 holders, $42.6bn | 20 holders, $16.4bn |
| Q4 2021 | 38 holders, $50.1bn | 20 holders, $16.8bn |
| Q1 2022 | 32 holders, $43.2bn | 28 holders, $13.2bn |
| Q2 2022 | 33 holders, $38.9bn | 26 holders, $13.6bn |
| Q3 2022 | 26 holders, $34.3bn | 24 holders, $13.3bn |
| Q4 2022 | 29 holders, $37.0bn | 32 holders, $21.1bn |
| Q1 2023 | 35 holders, $37.1bn | 27 holders, $21.8bn |
| Q2 2023 | 39 holders, $33.5bn | 24 holders, $20.7bn |
| Q3 2023 | 39 holders, $32.6bn | 24 holders, $20.0bn |
| Q4 2023 | 41 holders, $32.7bn | 22 holders, $21.5bn |
| Q1 2024 | 30 holders, $34.1bn | 30 holders, $20.3bn |
| Q2 2024 | 38 holders, $30.6bn | 28 holders, $18.5bn |
| Q3 2024 | 30 holders, $33.8bn | 29 holders, $24.2bn |
| Q4 2024 | 36 holders, $27.6bn | 28 holders, $25.9bn |
| Q1 2025 | 31 holders, $24.2bn | 33 holders, $32.0bn |
| Q2 2025 | 39 holders, $18.8bn | 27 holders, $30.9bn |
| Q3 2025 | 32 holders, $21.9bn | 23 holders, $29.4bn |
| Q4 2025 | 32 holders, $29.9bn | 25 holders, $34.3bn |
| Q1 2026 | 34 holders, $24.4bn | 25 holders, $38.5bn |
| Q2 2026 | 36 holders, $26.4bn | 26 holders, $34.2bn |
| Q3 2026 | 35 holders, $40.3bn | 31 holders, $38.6bn |
Thermo Fisher Scientific Inc
- Holders
- 32
- Reported value
- $29.9bn
- Buyers
- 27
- Sellers
- 20
Breadth +7 among 92 comparable managers.
Gilead Sciences Inc
- Holders
- 25
- Reported value
- $34.3bn
- Buyers
- 18
- Sellers
- 19
Breadth -1 among 92 comparable managers.
Who holds both, Q4 2025
Both (17)
AllianceBernstein LP, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Dodge & Cox, Fidelity (FMR LLC), Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP, Woodline Partners LP
Only TMO (15)
Artisan Partners LP, Baillie Gifford & Co, Farallon Capital Management LLC, GAMCO Investors Inc, Glenview Capital Management LLC, Harris Associates LP, Jane Street Group LLC, Markel Group Inc, Point72 Asset Management LP, Polen Capital Management LLC, Rokos Capital Management LLP, Steadfast Capital Management LP, Third Point LLC, Verition Fund Management LLC, Viking Global Investors LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.